Hvivo raises full year sales and earnings guidance after “excellent” start to 2023

📆 9/12/2023 9:54 AM
📰 businessposthq

⏱ Reading Time:
13 sec. here
2 min. at publisher
📊 Quality Score:
News: 9%
Publisher: 71%

Business News News

Business Business Latest News,Business Business Headlines

The Dublin-headquartered pharmaceutical services company said it expects to generate full year sales of £55m and earnings margins of 19 per cent

Hvivo, the Irish pharmaceutical services company founded by businessman Cathal Friel, has increased its sales and profit guidance for 2023 after reporting double-digit growth for the first six months of the year.

On Tuesday, the Dublin-headquartered company reported a 52 per cent increase in half year sales to £27.3 million on the back of new contract wins to run clinical trials and human challenge studies on behalf of large pharma and biotech companies.

Write Comment

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pharma services company Hvivo delivers record revenues in first halfCompany, formerly known as Open Orphan, described the first half of 2023 as ‘another period of excellent growth’
Source: IrishTimes - 🏆 3. / 98 Read more »